Predictors of protease inhibitor-associated adverse events
- 1 July 2001
- journal article
- clinical trial
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 55 (6) , 321-323
- https://doi.org/10.1016/s0753-3322(01)00070-1
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patientsAIDS, 2000
- Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug ReactionsAnnals of Internal Medicine, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral TherapyJAMA, 1998
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972